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The enhanced expression of IL-17-secreting T cells
during the early progression of atherosclerosis in
ApoE-deﬁcient mice fed on a western-type diet
Un Sil Jeon1, Jun-Pyo Choi2, You-Sun Kim3, Sung-Ho Ryu1 and Yoon-Keun Kim2
Atherosclerosis is a chronic progressive inﬂammatory disorder and the leading cause of cardiovascular mortality. Here we
assessed the dynamic changes of T-cell-derived cytokines, such as inteferon (IFN)-γ, interleukin (IL)-17 and IL-4, during the
progression of atherosclerosis in apolipoprotein E-null (ApoE− /−) mice, to understand the role of immune responses in different
stages of atherosclerosis. Male ApoE− /− mice were fed a high-fat, western-type diet (WD: 21% lipid, 1.5% cholesterol) after
5 weeks of age and were compared with C57BL/6 wild-type control mice fed a standard chow diet. Atherosclerotic lesions
appeared in the aortic sinus of ApoE− /− mice 4 weeks after WD and the lesions progressed and occupied >50% of the total
sinus area 16 weeks after WD. Aortic IL-17 mRNA and protein expression started to increase in ApoE− /− mice after 4 weeks on
the WD and peaked at around 8–12 weeks on the WD. In terms of systemic expression of T-cell-derived cytokines, IL-17
production from splenocytes after anti-CD3/CD28 stimuli increased from 4 weeks on the WD, peaked at 12 weeks and returned
to control levels at 16 weeks. The production of IFN-γ and IL-4 (Th1 and Th2 cytokines, respectively) from splenocytes was
delayed compared with IL-17. Taken together, the present data indicate that Th17 cell response may be involved at an early
stage in the development of atherosclerosis.
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INTRODUCTION
Atherosclerosis is a leading cause of cardiovascular disease and
death worldwide. It is now known as a chronic progressive
immune-mediated and inﬂammatory disorder involving large
and medium-sized arteries.1 Early atherosclerotic lesions are
characterized by the accumulation of fatty streaks consisting of
abnormal lipids, lipid-laden foam cells and T cells in the vessel
wall intima. With disease progression, more complicated
inﬂammatory processes are involved and atherosclerotic
plaques are covered with ﬁbrous caps form in the aortic vessel
walls. As they grow, plaques can narrow vascular lumens and
cause ischemic tissue injury. If an atherosclerotic plaque
ruptures, intravascular thrombosis can be catastrophic and
lead to fatal myocardial or cerebral infarction.
It is well known that both innate and adaptive immune
responses are involved in the pathogenesis of atherosclerosis.1
Macrophages have been known to have important roles in the
initiation and progression of atherosclerosis by forming foam
cells, the main component of fatty streaks, and by secreting
various inﬂammatory mediators.2 T cells, especially CD4+
T cells, are found in both human and rodent atherosclerotic
lesions.1 CD4+ T cells were classically subdivided into type 1
(Th1) and type 2 (Th2) cells according to their cytokine
expression patterns. Th1 cells secret interferon (IFN)-γ as the
major cytokine and have been shown to promote athero-
sclerosis in animal models and human studies.3 Recently, Th17
cells were identiﬁed as a distinct subset of CD4+ T cells and
were shown to secret interleukin (IL)-17 as their main
cytokine, as well as IL-6, CXCL-1, metalloproteinases, IL-21
and IL-22.4,5 Th17 cells are known to be important in various
autoimmune diseases, including multiple sclerosis, rheumatoid
arthritis and systemic lupus erythematosus, which were
previously regarded as Th1-mediated diseases.5–8
The pathogenic role of Th17 cells in the atherosclerosis
pathogenesis has been suggested in several studies.9 However,
data on the role of IL-17 in the atherosclerosis pathogenesis are
contradictory in apolipoprotein E-null (ApoE− /−) mice.10–14
In the present study we aimed to investigate the expression of
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cytokines derived from T-cell subsets (Th1, Th17 and Th2
cells) during the progression of atherosclerosis in ApoE− /−
mice fed a western-type diet (WD).
MATERIALS AND METHODS
Animals and study protocol
All live animal protocols were approved by the Pohang University of
Science and Technology Ethics Committee. Wild-type (WT) and
ApoE− /− mice on a C57BL/6 background were purchased from The
Jackson Laboratory (Bar Harbor, ME, USA) and bred in speciﬁc
pathogen-free conditions at the POSTCH Biotech Center. From
5 weeks of age, male control C57BL/6 mice were fed a standard chow
and male ApoE− /− mice were fed a WD (21% lipid, 1.5% cholesterol)
purchased from Dyets (Bethlehem, PA, USA) for a given period of
time (0–24 weeks). Chow and water were provided ad libitum. After 0,
1, 2, 4, 8, 12, 16, 20 and 24 weeks on standard chow or the WD, mice
were killed. At least ﬁve mice were used for each group at each time
point. The experimental protocol is shown in Figure 1.
Evaluation of physical changes and serum lipid level
During the experiment, body weight and blood pressure were
measured once a week for the ﬁrst 4 weeks and every 2–4 weeks
thereafter. Blood pressure was measured by a non-invasive tail-cuff
method (BP-2000 Blood Pressure Analysis System, Visitech Systems,
Apex, NC, USA) after acclimation. Blood and tissue samples were
taken from animals immediately after they were killed. Blood urea
nitrogen levels and serum lipid levels were measured by a commercial
service provider (Green Cross Reference Lab, Yongin-si, Korea).
Quantitation of atherosclerosis
C57BL/6 WT and ApoE− /− mice were anesthetized with ketamine.
Blood was collected from the orbital sinus and heart. Next, the mice
were perfused by cardiac puncture with cold phosphate-buffered saline
to wash out blood from the heart and all vessels.13 The whole aorta
from the thoracic to the abdominal aorta, including the common iliac
artery, was dissected under a stereo-microscope (as described below)
and the heart was removed. The surrounding fat and connective tissue
were removed carefully from the aorta when the aorta was dissected.
The part of the heart just below the atria, including the aortic root and
the base of the heart, was obtained, embedded vertically in optimum
cutting temperature medium and stored in liquid nitrogen. After
trimming, sequential frozen sections (thickness, 6 μm) were cut from
the point at which the three aortic valve leaﬂets of the aortic root
emerge. For quantitation of atherosclerosis, six cryosections (one per
50 μm) were selected to cover a 300-μm stretch of aorta (from the
aortic sinus to the ascending aorta) and were stained with Oil Red O
and counterstained with hematoxylin and eosin, as described
previously.15 Images were scanned and analyzed with the analySIS
software (Olympus Life and Material Science, Hamburg, Germany).
Atherosclerotic area was determined as the percentage of the cross-
sectional area of the aortic root that was stained by Oil Red O.
Reverse transcriptase-PCR analysis
Under a dissection microscope, the whole aorta was dissected carefully
by removing the adipose tissue and collecting all the layers of the
aorta. Aortic tissues were homogenized in TRIzol (Invitrogen,
Carlsbad, CA, USA), according to the manufacturer’s instructions.
Total RNA was extracted from the aorta and 1 μg of total RNA was
reverse transcribed using oligo-d(T) primers and AMV-RT Taq
polymerase (Promega, Madison, WI, USA), according to the manu-
facturer’s instructions. Real-time PCR was performed using Assay-on-
Demand TaqMan probes and primers speciﬁc for chemokine
receptor-2 (CCR2), IL-17, IL-12p40, IL-6 and GAPDH (Applied
Biosystems, Foster City, CA, USA) and an ABI PRISM 7500 Sequence
Detection System. The level of mRNA expression was normalized with
respect to the level of GAPDH mRNA expression.
Immunoblot analysis
Aortic tissues were homogenized in cold lysis buffer (10mM Tris
(pH 7.5), 1 mM sodium orthovanadate, 1% SDS). Protein concentra-
tion was measured by the bicinchoninic acid method (Bio-Rad,
Hercules, CA, USA). Homogenate samples were run on 10%
SDS-polyacrylamide gels and stained with Coomassie blue. Gel images
were scanned and quantiﬁed as described below, to adjust for equal
loading. After correction of protein concentrations, equal amounts of
protein were run on 10% SDS-polyacrylamide gels and electroblotted
onto a polyvinylidene diﬂuoride membrane (Millipore, Bedford, MA,
USA). The blots were blocked with 5% non-fat milk in PBS-T (80mM
Na2HPO4, 20mM NaH2PO4, 100mM NaCl, 0.1% Tween 20 pH 7.5)
for 30min at room temperature and then incubated overnight at 4 °C
with primary antibody (anti-ICAM-1 (Cell Signaling Technology,
Boston, MA, USA) or anti-IL-17 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA). After washing, the blots were incubated at room
temperature for 1 h with horseradish peroxidase-conjugated anti-
rabbit IgG (Cell Signaling Technology) diluted 1:5000 in blocking
Figure 1 An experimental protocol for the generation of atherosclerosis. Male C57BL/6 and ApoE− /− mice on a C57BL/6 background were
used. From 5 weeks of age, control C57BL/6 mice were fed a standard chow and ApoE− /− mice were fed a western-type diet (WD; 21%
lipid, 1.5% cholesterol). Each group at each time point contained at least ﬁve or six mice. Mice were euthanized at 0, 1, 2, 4, 8, 12, 16,
20 and 24 weeks on the WD.
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solution. Antibody binding was visualized using the enhanced
chemiluminescence system (Amersham Bioscience, Buckinghamshire,
UK). Speciﬁc bands were scanned and quantiﬁed using the Quantity
One software (Bio-Rad).
Intracellular cytokine staining
Splenocytes were obtained from mice and incubated at 37 °C for 6 h in
48-well plates coated with anti-CD3 and anti-CD28 antibodies
(1mgml− 1 each; eBioscience, San Diego, CA, USA). Cells were
stained for 30min at 4 °C with surface-speciﬁc antibodies (anti-
CD3-allophycocyanin, anti-CD4-FITC and anti-CD8-PE–Cy5; BD
Biosciences, Franklin Lakes, NJ, USA) and then ﬁxed and permea-
blized through incubation for 10min in 4% paraformaldehyde at
room temperature. Cells were incubated for 30min at room tem-
perature with antibodies speciﬁc for candidate cytokines (anti-IFN-γ–
PE, -IL-17–PE, -IL-4–PE and -IL-10-PE; BD Biosciences) and then
analyzed on a FACSCalibur ﬂow cytometer (BD Biosciences) using the
CellQuest software (CellQuest, Largo, FL, USA).
Enzyme-linked immunosorbent assay for cytokine
quantiﬁcation
Serum was collected when animals were killed. For T-cell
re-stimulation, 4.0 × 106 splenocytes per ml were obtained from the
spleen of each mouse and incubated with anti-CD3/28 antibodies
for 72 h. IL-6, IL-17 and IFN-γ levels in supernatants or sera were
measured by enzyme-linked immunosorbent assay, according to the
manufacturer’s instructions (R&D Systems, Minneapolis, MN, USA).
Statistical analysis
All values are presented as the means± s.e.m. Groups were compared
by non-parametric Mann–Whitney test and statistical signiﬁcance was
deﬁned as a P-valueo0.05.
RESULTS
Changes in physiologic and lipid proﬁles
Body weight and blood pressure were measured weekly for the
ﬁrst 4 weeks and then once every 2 or 4 weeks during the
experiment. There were no differences in body weight or
blood pressure between C57BL/6 mice on standard chow and
ApoE− /− mice on the WD (Figure 2a). When animals were
killed, serum was collected and blood urea nitrogen, serum
creatinine and lipid levels were analyzed. Blood urea nitrogen
and creatinine levels were not different between the two groups
(data not shown). At 5 weeks of age, total cholesterol levels
were higher in ApoE− /− mice than in C57BL/6 mice (91± 6.8
vs 345± 3.2 mg dl− 1, Po0.05; Figure 2b), even though all mice
had been fed standard chow; however, there were no signiﬁcant
Figure 2 Kinetics of physiologic and lipid parameters of atherosclerosis. (a) The change of body weight and blood pressure during
experiments. (b) Serum lipid levels. (c) Tissue weight-to-body weight ratio. *Po0.05 versus WT, ∧Po0.01 versus WT.
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differences in low-density lipoprotein (LDL)–cholesterol, tri-
glyceride or high-density lipoprotein–cholesterol levels between
these two groups. However, total cholesterol, LDL–cholesterol
and triglyceride levels dramatically increased in ApoE− /− mice
with 1 week on the WD (from 345± 3.2 to 975± 115.7 mg dl
− 1). High-density lipoprotein–cholesterol levels were lower in
ApoE− /− mice than in C57BL/6 mice (Po0.05) and were
maintained at similar levels during the experimental period
(Figure 2b). However, triglyceride levels were only higher in
ApoE− /− mice for the ﬁrst 12 weeks on the WD (71± 19.2 vs
174±
22.8mg dl− 1, Po0.01 at 2 weeks on the WD; 76± 81 vs
102± 8.5 mg dl− 1, P40.05 at 16 weeks on the WD). The
differences in total cholesterol and LDL–cholesterol levels
between the two groups had disappeared by that time.
Aorta weights and heart-to-body weight ratios were similar in
C57BL/6 and ApoE− /− mice at each time point, but spleen-to-
body weight ratio was higher in ApoE− /− mice (Po0.05;
Figure 2c). At 5 weeks of age, spleen-to-body weight ratio
was not different between C57BL/6 (4.9± 0.33 mg g− 1) and
ApoE− /− mice (5.1± 0.23 mg g− 1). The ratio increased sig-
niﬁcantly in ApoE− /− mice, reaching a value of 17.2± 2.04
mg g− 1 after 20 weeks on the WD (ratio 2.9± 0.11mg g− 1 in
C57BL/6 mice at the same age). These results suggest that a
systemic immune response was activated in WD-fed ApoE− /−
mice. No ApoE− /− or WT control mice died during the
experimental period (up to 30 weeks).
Development and progression of atherosclerosis in WD-fed
ApoE− /− mice
We ﬁrst observed the development and progression of athero-
sclerosis in ApoE− /− mice over time. Atherosclerosis was
quantiﬁed by measuring percentage Oil Red O-stained area
within the aortic sinus. Until 5 weeks of age, C57BL/6 and
ApoE− /− mice were fed a standard chow. At that time, no
signiﬁcant atherosclerotic lesions were found in C57BL/6 or
ApoE− /− mice (Figure 3). After 1 and 2 weeks on the WD, no
fatty streaks were observed in the aortic sinuses of ApoE− /−
mice (data not shown). Oil Red O-positive lesions ﬁrst
appeared in the aortic sinus of ApoE− /− mice (7.5% of the
total aortic sinus area; Figure 3) after 4 weeks on the WD (age
9 weeks). The sizes and areas of the atherosclerotic plaques
increased substantially over time (covering 24.6% of the total
aortic sinus area at 8 weeks on the WD, 51.3% at 16 weeks and
57.7% at 24 weeks). With increasing age, vascular walls showed
severe hyperplasia and the size of the atherosclerotic plaques
increased, causing stenosis of the vessel lumen. Internal
bleeding and thrombus were observed in some parts of plaques
at advanced disease stages. In contrast, no atherosclerotic
lesions were observed in control C57BL/6 mice during the
Figure 3 Photomicrographs of cross-sections of the aortic sinus of ApoE− /− mice. Aorta histologic ﬁndings. Upper panels are the results of
WT mice and lower panels are ApoE-deﬁcient mice (Oil Red O and hematoxylin and eosin counter staining, ×100 magniﬁcation). Enlarged
panel shows accumulation of lipid in the basement of aorta when 24 weeks after high-fat diet administration. For quantitation of
atherosclerotic lesions, the percentage of the total aortic sinus area stained by Oil Red O was determined. *Po0.05 versus WT.
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experimental period. Thus, atherosclerotic lesions developed at
very young ages in ApoE− /− mice fed the WD and the disease
progressed rapidly to advanced lesions over time.
Production of pro-inﬂammatory mediators during the
course of atherosclerosis
As atherosclerosis is a chronic inﬂammatory disorder, we
assessed dynamic changes in well-known mediators during
the course of atherosclerosis in ApoE− /− mice. Monocyte
accumulation in vascular walls is the earliest step in the
formation of atherosclerotic plaques and has an important
role in disease progression.1,2 We ﬁrst observed changes in the
expression of intracellular adhesion molecule (ICAM)-1 and
CCR2, important mediators of the recruitment of monocytes
to vascular walls.16,17 The level of ICAM-1 protein in the aorta
was measured by immunoblotting. The expression of ICAM-1
protein was higher in ApoE− /− mice on the WD than in
control mice as early as 2 weeks on the WD (Figure 4a). The
protein level peaked at 12 weeks on the WD and was
maintained at a higher level in ApoE− /− mice, even though
the fold increase was reduced at later stages. The expression of
CCR2 mRNA in the aorta was higher in ApoE− /− mice than in
control mice from experimental week 2 (7 weeks of age)
(Figure 4b). The change in CCR2 mRNA expression showed a
very similar pattern to that of ICAM-1 protein, but the fold
increase in CCR2 mRNA expression in ApoE− /− mice peaked
slightly earlier than that of ICAM-1 protein (Figure 4b).
IL-6 is an important regulator of immune responses and is
known to be involved in the pathogenesis of atherosclerosis.3,18
In addition, IL-6 is a key promoter of Th17 cell
differentiation.4,19 In the current study, we assessed dynamic
changes in aortic IL-6 expression during the course of
atherosclerosis. The expression of IL-6 mRNA increased in
the aorta of ApoE− /− mice as early as 2 weeks on the WD
(7 weeks of age), similar to ICAM-1 protein and CCR2 mRNA
(Figure 5a). Interestingly, the increases in these mediators
occurred before any atherosclerotic lesions were detected by
microscopy. The level of IL-6 mRNA reached in Apo− /− mice
peaked after 12 weeks on the WD (116-fold increase compared
to the level in WT mice). Serum IL-6 protein (measured by
enzyme-linked immunosorbent assay) showed the tendency of
increase in ApoE− /− mice on the WD, but not in WT mice
(Figure 5b). Serum levels of IL-6 in ApoE− /− mice were 9.5
pgml− 1 at 4 weeks on the WD, 53.3 pgml− 1 at 16 weeks and
18.2 pgml− 1 at 12 weeks. We could not calculate P-values of
serum IL-6 levels for comparison between WT and ApoE− /−
mice, except 16 weeks data, because IL-6 was not detected in
WT mice. The data showed that serum IL-6 levels increased in
Figure 4 Kinetic changes in pro-inﬂammatory mediator expression in ApoE− /− and control mice. For all ﬁgures, evaluation were done in
various time point; y axis: relative ratio of ICAM-1 or CCR2 levels in ApoE− /− mice to that in WT C57BL/6 mice. *Po0.05 versus WT.
(a) The immunoblotting results of ICAM-1 protein expression in aorta tissue. Left: result of immunobloting ﬁlm; right: quantiﬁcation results
by band scanning. (b) The change of CCR2 mRNA expression level in aorta tissue.
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ApoE− /− mice with the development of atherosclerosis. How-
ever, there was no direct correlation between the serum IL-6
levels and aortic expression of IL-6 mRNA (data not shown).
Kinetic changes in IL-17 and IFN-γ expression in aorta
tissues
The role of IL-17 in atherosclerosis remains unclear. Some
studies showed that IL-17 accelerated the progression of
atherosclerosis in animal models,11,12 but others showed the
opposite.14 We evaluated serial changes in IL-17 expression in
the aorta according to the development and progression of
atherosclerosis over time. Total RNA and protein were
obtained from the aortas of mice. The expression of IL-17
mRNA was measured by real-time quantitative PCR. At 5 weeks
of age, the expression of IL-17 mRNA was very low and
undetectable in most ApoE− /− and WT mice on standard
chow. IL-17 mRNA was only detected in the aorta of ApoE− /−
mice on the WD and a few WT mice (Figure 6a, left). The level
of IL-17 mRNA increased in ApoE− /− mice after 4 weeks on
the WD and peaked at 8 weeks on the WD. We could not
perform statistical comparisons, because IL-17 mRNA was only
detected in a few WT mice. IL-17 protein levels were measured
by immunoblotting and were shown to be higher in ApoE− /−
mice compared with control mice, especially after 12 weeks on
the WD (Figure 6a, right).
IFN-γ is the main cytokine of Th1 cells and known to be
involved in the pathogenesis of atherosclerosis.1,20 We also
measured the expression of IFN-γ and IL-12p40 mRNA in the
whole aorta by real-time quantitative PCR. Those mRNA
showed patterns of change that were similar to those of
IL-17 (Figure 6b).
Systemic T-cell responses during the course of
atherosclerosis
Finally, systemic T-cell responses during the course of athero-
sclerosis were evaluated. Splenocytes were obtained from mice
at the time at which they were killed and were prepared for
intracellular staining of cytokines. Flow cytometry analysis
was performed using anti-IL-17, anti-IL-4, anti-IL-10 and
anti-IFN-γ antibodies. With regard to Th17 cell expression
(Figure 7a), the percentages of CD4+IL-17+ splenocytes were
not different between control and ApoE− /− mice at 0 and
2 weeks on the WD. The percentage of CD4+IL-17+ spleno-
cytes was higher in ApoE− /− mice compared with C57BL/6
mice after 4 weeks on the WD (0.09± 0.0 vs 0.28± 0.04,
Po0.05) and remained increased until 12 weeks on the WD
(0.71± 0.16 vs 3.21± 0.59, Po0.05). However, the increase in
the percentage of CD4+IL-17+ splenocytes in ApoE− /− mice
was blunted after 16 weeks on the WD (0.91± 0.32 vs
1.63± 0.50, P40.05). There were no differences in the
numbers of CD4+ IFN-γ+ splenocytes between control and
ApoE− /− mice at the early stages of atherosclerosis (Figure 7a).
At 12 weeks on the WD, the percentage of CD4+IFN-γ+
splenocytes was higher in ApoE− /− mice compared with
control mice (1.92± 0.15 vs 6.60± 1.37, Po0.05). The percen-
tage of CD4+IL-4+ splenocytes was not different between
WD-fed ApoE− /− and control mice at most time points,
but was higher in ApoE− /− mice at 12 weeks on the WD
(0.71± 0.12 vs 2.52± 0.54, Po0.05). As the proportion of
splenic Th1 and Th17 cells in ApoE− /− mice on the WD
peaked at 12 weeks, cytokine levels were measured in super-
natants from anti-CD3/CD28-stimulated splenocytes obtained
from mice at that time point. This experiment showed that the
production for IL-17 was signiﬁcantly increased in ApoE− /−
mice than in C57BL/6 mice, whereas that of IFN-γ was not
(Figure 7b).
DISCUSSION
In the present study we assessed the morphology and kinetic
changes in IL-17 and various mediators from the initiation to
the late stages of atherosclerosis in ApoE− /− mice on a WD.
We found that aortic expression of IL-17 protein and mRNA
increased in ApoE− /− mice at an early stage of atherosclerosis.
In addition, expression of the inﬂammatory mediators CCR2,
ICAM-1 and IL-6 increased in the aorta of ApoE− /− mice
before development of any morphologic lesions.
We used ApoE− /− mice as an animal model of athero-
sclerosis, because atherosclerotic lesions in ApoE− /− mice are
Figure 5 Kinetic changes in IL-6 expression in ApoE− /− and control mice. For all ﬁgures, y-axis: relative ratio of IL-6 level in ApoE− /− mice
to that in control C57BL/6 mice. *Po0.05 versus WT. (a) The expression level of IL-6 mRNA in aorta tissue following WD administration
for 24 weeks. (b) The expression of IL-6 protein in serum on each time point.
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known to be very similar to those in humans.21 Normally,
atherosclerosis occurs spontaneously in ApoE− /− mice, but
western diets containing high levels of lipids cause athero-
sclerosis to occur earlier and be more severe than does a
normal standard diet.21 Therefore, we compared WD-fed
ApoE− /− mice with WT mice fed a standard chow diet to
make the differences between the groups more distinct.
We measured atherosclerotic lesions within the aortic sinus,
because this is usually the ﬁrst site of development of
atherosclerotic lesions in ApoE− /− mice.15,21
In our model, atherosclerotic plaques developed in the aortic
sinus as early as 9 weeks of age (4 weeks on the WD),
consistent with a previous report.15 The atherosclerotic lesions
showed rapid progression and increased steadily in size and
extent over time. Interestingly, we found that an inﬂammatory
response preceded any visible morphologic atherosclerotic
changes. At 5 weeks of age, when both WT and ApoE− /−
mice had been fed standard chow, there was no difference in
the expression of ICAM-1, CCR2 or IL-6 between these two
groups. However, expression of these mediators started to
increase at 2 weeks in WD-fed ApoE− /− mice. In our model,
serum cholesterol and LDL–cholesterol levels were higher in
ApoE− /− mice than in control mice at baseline (5 weeks of
age), but dramatically increased in ApoE− /− mice after only
1 week on the WD. Considering that hyperlipidemia and
subsequent formation of ox-LDL induce endothelial cell
damage to initiate the inﬂammatory reactions, and that both
ICAM-1 and CCR2 have important roles in adhesion and the
recruitment of monocytes during the development of fatty
streaks on vascular walls, the occurrence of inﬂammation
before the formation of fatty streaks would be relevant.
A previous study demonstrated that most pro-inﬂammatory
mediators reached maximum levels after about 10 weeks
in ApoE− /− mice on a WD, which were consistent with
our present data.22 Taken together, these data suggest that
inﬂammatory processes are important in the development of
atherosclerosis, especially at the early stages.
According to previous observations, ﬁbrous capsule matura-
tion on the surface of atherosclerotic plaques occurs at a late
stage of atherosclerosis.15,22,23 Therefore, chronic processes
such as ﬁbrosis, acute inﬂammatory processes, may be the
major pathologic processes at late disease stages. Despite the
Figure 6 Kinetic changes in IL-17 expression in ApoE− /− and control mice. For all ﬁgures, y-axis: relative ratio of the level in ApoE− /−
mice to that in control C57BL/6 mice. *Po0.05, ∧Po0.01 versus WT. (a) The expression of IL-17 mRNA and protein in aorta tissue. (left
panel: result of mRNA expression; right: immunoblot analysis). (b) The expression of IFN-γ mRNA in aorta.
Enhanced Th17 inﬂammation in atherosclerosis
US Jeon et al
7
Experimental & Molecular Medicine
continuous enlargement of atherosclerotic lesions over time,
the present study showed that the expression of ICAM-1,
CCR2 and IL-6 reached peak levels at 12–16 weeks on the WD
(17–21 weeks of age), and that fold increases in ApoE− /− mice
subsequently decreased. Pro-inﬂammatory mediators showed
very similar patterns of expression during the course of
atherosclerosis: (1) increased levels at a very early stage, before
the development of visible atherosclerotic plaques; (2) peak
levels at about 8–12 weeks on the WD; and (3) reduced fold
increase at late stages of atherosclerosis. Considering the
complicated machinery involved in the pathogenesis of athero-
sclerosis, these data suggest that the main pathogenic factor(s)
in atherosclerosis progression at late disease stages may be
related to tissue remodelling rather than inﬂammation.
It is well documented that serum IL-17 levels in
atherosclerosis patients increase during acute coronary
syndrome,9,10 and that IL-17 is found in atherosclerotic lesions
in both humans and animals.1,9 Our data suggest that the
expression of IL-6 preceded the Th17 cell response. IL-6 is a
key mediator in the development of Th17 cell responses.19
In addition, IL-6 is known to be a downstream mediator
of the effects of IL-17.19 Taken together, these ﬁndings suggest
that WD-induced production of IL-6 is a key pathogenic
process in the development of adaptive immune dysfunction in
ApoE− /− mice.
To our knowledge, no previous study has evaluated kinetic
changes in IL-17 and related molecules during the course of
atherosclerosis. We found the IL-17 levels in the aorta and
spleen increased in WD-fed ApoE− /− mice, consistent with
previous reports.9,11 The expression of IL-17 in the aorta was
very low or not detected in C57BL/7 mice (regardless of age)
and ApoE− /− mice at 5 weeks of age, and fed standard chow.
In ApoE− /− mice, aortic expression of IL-17 started to increase
after 4 weeks on the WD (9 weeks of age), the time at which
visible atherosclerotic lesion appeared in the aortic sinus. Even
though its expression increased slightly later than that of CCR2,
IL-6 and ICAM-1, IL-17 appears to have a role from the very
early stages of atherosclerosis. Th1 cells have a key role in the
pathogenesis of atherosclerosis.1,3 Therefore, we assessed
kinetic changes in IFN-γ, the key cytokine of Th1 cells, and
IL-12p40, a component of both IL-12 and IL-23. The expres-
sion of these cytokines was increased in WD-fed ApoE− /− mice
in the aorta and splenocytes. However, the increase of IL-12p40
mRNA in the aorta and IFN-γ in the spleen occurred later than
the change in IL-17 expression. In addition, when we were
evaluating the level of IL-12p70 in serum we did not conﬁrm
the expression in that time. We supposed that the reason of
high Th17 immune responses is caused by low Th1 cell
development through low expression of IL-12p70 in this
animal model and IFN-γ-positive T cell-detection is caused
by ‘T-cell plasticity’, the conversion of Th17 cell to Th1 cell,
Figure 7 The systemic expression of T-cell-derived cytokines in ApoE− /− and control mice. (a) The proportion of IL-17-, IFN-γ- and IL-4-
positive CD4 T cells in splenocytes. (b) The production of IL-17 and IFN-γ from splenocytes at 12 weeks after anti-CD3/CD28 stimulation.
*Po0.05 versus control.
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as increase of IL-12p40 and IFN-γ showed the ‘interval’
compared with IL-17 expression and IL-12p40 is related with
T-cell plasticity.24 To sum up, these data suggest that Th17
cell responses may be important in the atherosclerosis
pathogenesis.
In summary, we found that IL-17 expression was increased
from the very early stages of atherosclerosis, and that produc-
tion of proinﬂammatory mediators was increased before
morphologic changes occurred. However, the expression of
IL-17 and proinﬂammatory mediators was reduced at the
advanced stages of atherosclerosis. Therefore, early intervention
to modulate immune dysfunction might be effective for
preventing the development and progression of atherosclerosis.
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